Starcef DS powder for syrup

Dexa Medica

Ingredients in every 5 ml

Cefixime 100 mg

Each package contains

1 bottle of 30 ml

Other details

Dosage form:Powder for syrup
Flavour None

W.H.O. classification

ATC Level 1 J - Antiinfectives for systemic use
ATC Level 2 J01 - Antibacterials for Systemic Use
ATC Level 3 J01D - Other Beta-Lactam Antibacterials in ATC

Warnings

Pregnancy

CONSULT YOUR DOCTORSafety of this item for use during pregnancy has not been established. Please consult your doctor.

Lactation

CONSULT YOUR DOCTORSafety of this item for use during lactation has not been established. Please consult your doctor.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CONSULT YOUR DOCTORSafety of this item for use while operating heavy machinery has not been established. Please consult your doctor.

Available in

Indonesia
Myanmar
Cambodia

Dosage information

0 TO 18 YEARS OLD
The usual daily dose for pediatric is 1.5-3 mg (0.075-0.15 ml of Starcef dry syrup)/kg body weight given orally twice a day. Dosage should be adjusted according to the condition of the patients. For severe infections, the dosage may be increased up to 6 mg (0.3 ml of Starcef dry syrup)/kg body weight given twice a day.

In pediatrics with otitis media, it is recommended to treat with Starcef dry syrup. Otitis media which treated with Starcef dry syrup resulted in higher plasma concentration than the tablet (capsule) when administered at the same dose. Therefore, the suspension should not be substituted in the treatment of otitis media.

Reconstitution of dry syrup:
Add 10 ml of water, shake for 30 seconds. Add 10 ml more of water and shake again for 30 seconds.

PATIENTS WITH IMPAIRED RENAL FUNCTION
Patients with impaired renal function need a dosage adjustment depending on the degree of renal impairment. Recommended dosage: 75% of the standard dosage (i.e. 300 mg a day) if creatinine clearance is between 21 and 60 ml/minute or for patients on renal hemodialysis and 50% of the standard dosage (i.e. 200 mg a day) if creatinine clearance is <20 ml/minute or for patients on continuous ambulatory dialysis.

Indication

Treatment of infections caused by susceptible microorganisms, i.e.:
a. Urinary infections without complication caused by Escherichia coli and Proteus mirabilis.

b. Otitis media caused by Haemophilus influenzae (ß-lactamase positive and negative strains), Moraxella (Branhamella) catarrhalis (most of which are ß-lactamase positive) and Streptococcus pyogenes.

c. Pharyngitis and tonsillitis caused by Streptococcus pyogenes.

d. Acute bronchitis and acute exacerbation of chronic bronchitis, caused by Streptococcus pneumoniae and Haemophilus influenzae (ß-lactamase positive and negative strains).